Thomas Li, Sr Director at Roche to Speak at 3rd Oncology Biomarkers Conference on Jan 27-28, 2011 CA
Summary
Topics will include microarray, amplification, melting curve analysis, immunoassay, autoantibodies, antibody technology, multiplexing, mass spectrometry, immunohistochemistry, in situ hybridization, comparative genomic hybridization, copy number variation, sequencing, flow cytometry, digital imaging, bioinformatics and pathway analysis.Dr. Li is also an Associate Member of the Early Detection Research Network at The National Cancer Institute (USA).Topics will include microarray, amplification, melting curve analysis, immunoassay, autoantibodies, antibody technology, multiplexing, mass spectrometry, immunohistochemistry, in situ hybridization, comparative genomic hybridization, copy number variation, sequencing, flow cytometry, digital imaging, bioinformatics and pathway analysis.Li rose through the scientific and managerial ranks of Rx and DX companies such as Miles Laboratories (Bayer), Syntex (Roche), Hycor (Strategene/Agilent), and the Diagnostic Products Corporation (Siemens), before joining Invitrogen (ABI) and then Roche.Dr.He has launched over 52 510K and PMA IVD products and 6 Instruments.### Contact Information GTCbio David Stoops 626-256-6405 http://www.gtcbio.com 434 W. Foothill Blvd.